Investors

EnChannel Medical is a pioneering cardiac technology company dedicated to the development of critically needed diagnostic and therapeutic solutions for individualizing treatment for patients with complex cardiac arrhythmias.

EnChannel Medical’s products include the DePolar® Arrhythmia Mapping System, a third-generation, state-of-the-art arrhythmia mapping platform that promises improved accuracy via hybrid magnetic and impedance navigation plus seamless integration of contact and non-contact mapping. In parallel with the arrhythmia mapping system, EnChannel is also developing a pulsed field ablation (PFA) therapy system which includes the NanoAblate® PFA Generator and PFBalloon® and PFApple™ ablation catheters. When used together, these products enable personalized atrial fibrillation (AF) treatment through precise identification and non-thermal destruction of the sources responsible for both regular and irregular cardiac arrhythmias.

9 + 9 =

Please use the contact form if you are interested in learning more about EnChannel Medical.